Osteopathic Manual Therapy Versus Ganglion Impar Block for Chronic Coccygodynia
CompletedNot applicableNCT07642167
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to compare two treatment methods for chronic coccygodynia (tailbone pain) in adults. The study aims to determine which treatment provides better pain relief and functional improvement. The main questions it aims to answer are: Does osteopathic manual therapy reduce pain and disability in people with chronic coccygodynia? Does ganglion impar block reduce pain and disability in people with chronic coccygodynia? Which treatment provides more sustained improvement during follow-up? Researchers will compare osteopathic manual therapy with ganglion impar block to evaluate their effects on pain, function, quality of life, and patient satisfaction. Participants will: Be randomly assigned to one of the two treatment groups. Receive either osteopathic manual therapy or ganglion impar block. Complete pain, disability, neuropathic pain, and quality-of-life assessments before treatment and during follow-up visits. Attend follow-up evaluations at 3 weeks and 3 months after treatment.
Study details
- Official title
- Comparison of Osteopathic Manual Therapy and Ganglion Impar Block in Patients With Chronic Coccygodynia: A Prospective Randomized Controlled Trial
- Conditions
- Chronic Coccygodynia
- Interventions
- Procedure: Osteopathic Manual Therapy
- Procedure: Ganglion Impar Block
- Sponsor
- Atlas University
- Start date
- 2025-08-28
- Primary completion
- 2026-03-12
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Age 18-75 years Chronic coccygodynia persisting for at least 3 months Unresponsive to previous conservative treatment Baseline NRS score ≥4 Baseline ODI score ≥20 Written informed consent Exclusion Criteria: Acute coccygodynia Previous coccygeal or spinal surgery Malignancy Pelvic fracture Pregnancy Coagulation disorders Severe psychiatric disease Previous osteopathic manual therapy or ganglion impar block Structural pathology identified on MRI or dynamic radiography
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07642167